Clinical Trials Directory

Trials / Terminated

TerminatedNCT02592863

Trental for the Treatment of Vertigo/Dizziness/Imbalance

A Double-Blind, Placebo-Controlled, Randomized Trial of Pentoxifylline for Imbalance Secondary to Insufficient Microvascular Perfusion

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
26 (actual)
Sponsor
University of Missouri-Columbia · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

Imbalance, dizziness and vertigo as a result of problems in the inner ear (vestibular dysfunction) are becoming increasingly more prevalent in Americans 40 years of age and older. The symptoms have a severe impact on affected individuals with detrimental effects on work, travel, social and family life. These patients see doctors often with no relief in their symptoms. The most promising help for these patients is to use medication that will increase blood flow to the inner ear. Pentoxifylline (Trental) has been shown to increase microvascular blood flow.

Detailed description

One potential cause of vestibular dysfunction is a decrease in or insufficient blood flow to the inner ear. Studies have shown that when the blood flow is decreased to the inner ear, patients will become dizzy and off balance. This study will use validated instruments to evaluate the effectiveness of Trental in patients that present to our providers with vertigo, dizziness, or imbalance and meet inclusion criteria. They will be blinded and randomized to treatment or placebo, which they will take for \~12 weeks. Patients will completed validated surveys 3 times (beginning, middle and end of study) as well as account for the number of times they have fallen and if they have missed any work due to their symptoms.

Conditions

Interventions

TypeNameDescription
DRUGPentoxifyllinePatients will take Trental (Pentoxifylline) 3 times per day for 12 weeks
DRUGPlaceboPatients will take placebo 3 times per day for 12 weeks

Timeline

Start date
2015-01-01
Primary completion
2020-12-31
Completion
2021-04-12
First posted
2015-10-30
Last updated
2024-10-15
Results posted
2024-10-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02592863. Inclusion in this directory is not an endorsement.